drugset / Trial / NCT01369147
The Energy Dose Study
Phase 2
Terminated
12 enrolled
Emory University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupTriple-blindSupportive care
Summary
The investigators have designed this single-center Randomized Clinical Trial (RCT) to prospectively compare, for the first time, the clinical efficacy of different energy doses in intensive care unit (ICU) patients requiring parenteral nutrition (PN) due to intestinal failure/dysfunction. This study intends to enroll a total of 60 patients (20 per energy dose group) to generate critical preliminary data needed to inform subsequent appropriately powered Phase III multicenter trials.
Timeline
- Start
- 2011-07
- Primary completion
- 2014-12-02
- Completion
- 2014-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Clevidipine | Small molecule | — | — |
| Background | Propofol | Small molecule | — | — |
Indications
No indication recorded.